Showing results (161-170 of 198) with videos related to

Sort By:
Pageof 20
British Journal of Haematology|February 15, 2013
Genetic determinants of haemolysis in sickle cell anaemiaJacqueline N Milton, Helen Rooks, Emma Drasar, et al.
Blood|June 5, 2013
Acute myeloid leukemia creates an arginase-dependent immunosuppressive microenvironmentFrancis Mussai, Carmela De Santo, Issa Abu-Dayyeh, et al.
Nature Genetics|September 15, 2015
Genome-wide association analyses based on whole-genome sequencing in Sardinia provide insights into regulation of hemoglobin levelsFabrice Danjou, Magdalena Zoledziewska, Carlo Sidore, et al.
Blood Cells, Molecules & Diseases|April 2, 2022
Mitapivat increases ATP and decreases oxidative stress and erythrocyte mitochondria retention in a SCD mouse modelZenaide M N Quezado, Sayuri Kamimura, Meghann Smith, et al.
Experimental Hematology|April 1, 2021
Combination of azacitidine and enasidenib enhances leukemic cell differentiation and cooperatively hypomethylates DNAKyle J MacBeth, Vivek S Chopra, Lin Tang, et al.
Biorxiv : the Preprint Server for Biology|March 18, 2026
A population-scale Red Blood Cell proteome atlas of 13,000 donors uncovers genetically encoded aging clocks predicting hemolysis, transfusion efficacy, and donor activity a decade laterMonika Dzieciatkowska, Aaron V Issaian, Gregory R Keele, et al.
Blood|March 4, 2021
Circulating mitochondrial DNA is a proinflammatory DAMP in sickle cell diseaseLaxminath Tumburu, Shohini Ghosh-Choudhary, Fayaz T Seifuddin, et al.
Trials|January 24, 2018
Overnight auto-adjusting continuous airway pressure + standard care compared with standard care alone in the prevention of morbidity in sickle cell disease phase II (POMS2b): study protocol for a randomised controlled trialJo Howard, April E Slee, Simon Skene, et al.
Blood|February 18, 2009
A novel variant on chromosome 7q22.3 associated with mean platelet volume, counts, and functionNicole Soranzo, Augusto Rendon, Christian Gieger, et al.
The Lancet. Haematology|December 7, 2024
Safety and efficacy of mitapivat in sickle cell disease (RISE UP): results from the phase 2 portion of a global, double-blind, randomised, placebo-controlled trialModupe Idowu, Lucas Otieno, Bogdan Dumitriu, et al.
Pageof 20